HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Chiara Buscarinu Selected Research

ocrelizumab

10/2022Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Chiara Buscarinu Research Topics

Disease

24Multiple Sclerosis
02/2024 - 01/2013
7Relapsing-Remitting Multiple Sclerosis
08/2021 - 01/2018
3COVID-19
01/2023 - 01/2020
3Infections
10/2022 - 11/2020
3Autoimmune Diseases (Autoimmune Disease)
01/2020 - 11/2015
2Huntington Disease (Huntington's Disease)
03/2023 - 01/2021
2Vitamin D Deficiency
01/2022 - 01/2019
2Fatigue
10/2021 - 03/2020
1Rare Diseases (Rare Disease)
02/2024
1Latent Infection
01/2022
1Neuromyelitis Optica (Devic's Disease)
01/2022
1Transverse Myelitis (Necrotizing Myelitis)
01/2022
1Lymphopenia (Lymphocytopenia)
06/2021
1Dysbiosis
05/2021
1Genetic Risk Score
01/2020
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2019
1Autoimmune Diseases of the Nervous System
10/2019
1Partial Epilepsies (Epilepsy, Partial)
10/2019
1Encephalitis (Encephalitis, Rasmussen)
10/2019
1Aphasia (Dysphasia)
10/2019
1Inflammation (Inflammations)
01/2018
1Low Vision (Subnormal Vision)
01/2016
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
01/2016
1Eosinophilic enteropathy
01/2016
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2015
1Sarcoma (Soft Tissue Sarcoma)
01/2013

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
03/2023 - 01/2019
4Dimethyl FumarateIBA
06/2021 - 01/2016
3Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2013
3Interferon Type IIBA
01/2020 - 01/2013
3InterferonsIBA
01/2019 - 10/2016
2Natalizumab (Tysabri)FDA Link
02/2024 - 09/2022
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2020
2Alemtuzumab (Campath)FDA Link
10/2019 - 12/2018
1Messenger RNA (mRNA)IBA
01/2023
1VaccinesIBA
01/2023
1BNT162 VaccineIBA
01/2023
1Glycoproteins (Glycoprotein)IBA
01/2023
1Antiviral Agents (Antivirals)IBA
10/2022
1ocrelizumabIBA
10/2022
1nitazoxanide (NTZ)FDA Link
09/2022
1COVID-19 VaccinesIBA
01/2022
1teriflunomideIBA
08/2021
1Glatiramer Acetate (Copaxone)FDA Link
11/2020
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2019
1Inosine Triphosphate (ITP)IBA
10/2019
1SteroidsIBA
10/2019
1AntibodiesIBA
10/2019
1Interferon beta-1b (Betaseron)FDA Link
01/2019
1Fingolimod Hydrochloride (FTY720)FDA Link
10/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018
13-nitrotyrosineIBA
01/2016
1NitratesIBA
01/2016
1NitritesIBA
01/2016
1NitrogenIBA
01/2016
1Oxygen (Dioxygen)IBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
1Reactive Nitrogen SpeciesIBA
01/2016
1Interleukin-2 (IL2)IBA
11/2015
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
03/2015
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2013
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2013

Therapy/Procedure

12Therapeutics
02/2024 - 09/2015
2Injections
03/2020 - 05/2018